Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Overall, the studies aimed to rigorously assess whether bremelanotide could provide a meaningful improvement in sexual desire and distress among women with HSDD, with safety and tolerability also closely monitored throughout the trial periods [1]
Level E (lowest) : case reports/series and patient-reported outcomes outside clinical systems (useful for pattern recognition
The products sold on this website are separate from the content of the articles and are not directly endorsed or associated with the information presented here
10.1016/S0014-5793(97)00561-9
US$ 21.32
US$ 21.97
US$ 21.81
US$ 24.43
US$ 25.43
